XML 15 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 74,755 $ 71,367
Marketable securities 161,264 195,317
Accounts receivable 1,623 1,504
Related party collaboration receivable (see note 8) 487 676
Prepaid expenses and other current assets 7,077 7,945
Total current assets 245,206 276,809
Property and equipment, net 13,929 14,314
Restricted cash 2,874 2,874
Marketable securities, non-current 59,103 65,704
Operating lease, right-of-use assets 32,128 33,349
Total assets 353,240 393,050
Current liabilities:    
Accounts payable 2,634 3,996
Accrued expenses 9,053 14,171
Operating lease liabilities 7,430 7,227
Deferred revenue (see Note 8) 21,095 24,394
Total current liabilities 40,212 49,788
Operating lease liabilities, net of current portion 34,566 36,499
Deferred revenue, net of current portion 4,760 6,003
Other non-current liabilities 1,000 1,000
Total liabilities 80,538 93,290
Commitments and contingencies (see note 7)
Stockholders' equity:    
Preferred stock, $0.001 par value: 5,000,000 shares authorized at March 31, 2025 and December 31, 2024; no shares issued and outstanding at March 31, 2025 and December 31, 2024
Common stock, $0.001 par value: 120,000,000 shares authorized at March 31, 2025 and December 31, 2024; 55,209,485 and 54,731,316 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 55 55
Additional paid-in capital 630,051 626,296
Accumulated other comprehensive loss (199) (407)
Accumulated deficit (357,205) (326,184)
Total stockholders' equity 272,702 299,760
Total liabilities and stockholders' equity $ 353,240 $ 393,050